Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice
about
TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3betaGlycogen synthase kinase 3: more than a namesakeGlycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeuticsChronic over-nutrition and dysregulation of GSK3 in diseasesNutritional programming in the rat is linked to long-lasting changes in nutrient sensing and energy homeostasis in the hypothalamusHepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseasesEndoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transitionKnockdown of GSK3β increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cellsValproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis.Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistanceGSK-3beta and control of glucose metabolism and insulin action in human skeletal muscleSynthesis and evaluation of [(11)C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3β (GSK-3β)Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in ratsEffect of aging on cellular mechanotransductionGlycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility.Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3.Conditional ablation of Gsk-3β in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in miceGSK3 takes centre stage more than 20 years after its discovery.Jejunal proteins secreted by db/db mice or insulin-resistant humans impair the insulin signaling and determine insulin resistanceTauroursodeoxycholic acid mitigates high fat diet-induced cardiomyocyte contractile and intracellular Ca2+ anomalies.GSK3β is increased in adipose tissue and skeletal muscle from women with gestational diabetes where it regulates the inflammatory responseGene-environment interactions controlling energy and glucose homeostasis and the developmental origins of obesityPhosphorylation and inactivation of glycogen synthase kinase 3β (GSK3β) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity.Differential effects of exposure to maternal obesity or maternal weight loss during the periconceptional period in the sheep on insulin signalling molecules in skeletal muscle of the offspring at 4 months of age.Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasisRole of caveolin and caveolae in insulin signaling and diabetes.Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.Synthesis and Initial in Vivo Studies with [(11)C]SB-216763: The First Radiolabeled Brain Penetrative Inhibitor of GSK-3.Long-Term Over-Expression of Neuropeptide Y in Hypothalamic Paraventricular Nucleus Contributes to Adipose Tissue Insulin Resistance Partly via the Y5 ReceptorHigh-fat load: mechanism(s) of insulin resistance in skeletal muscle.Inhibition of glycogen synthase kinase-3β enhances cognitive recovery after stroke: the role of TAK1.Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty ratsInhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition.Vibration exercise decreases insulin resistance and modulates the insulin signaling pathway in a type 2 diabetic rat modelRetinoic acid protects cardiomyocytes from high glucose-induced apoptosis through inhibition of NF-κB signaling pathwayTargeting glycogen synthase kinase-3 in insulin signalling.Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3.Circadian rhythms and the regulation of metabolic tissue function and energy homeostasis.
P2860
Q24311416-FD8AEA32-959A-40FE-BE3D-923A07C267CBQ24315635-63AD4439-2914-488E-8076-C21D96DE0E01Q24685475-FA7A700C-A506-48FF-A23F-1B8260FF0687Q26738964-0782A8D8-0F27-48A3-9506-D932E1A5D18EQ27317339-939734C0-ECAC-4A1A-A2FF-90469FF68BCBQ28509645-BDBBD592-FDC9-431F-A6D7-B26297394212Q28577217-7D4F6BD6-BD02-43C2-8C9C-E286CCAC3E8EQ28830062-EC5F09D6-8DC2-4317-9E75-EC70640D5521Q30485641-3DBBC5BF-68E9-4E4F-B4FD-9BCC8CCDE678Q33320681-D9D959A1-E9BC-4088-A247-777083811F89Q33641305-FC514AB3-1117-4A77-8CDB-EEEE7207698AQ33664977-895E28EF-51EF-40B2-A170-8728E6D87144Q33765864-000080B2-3F02-48BA-80D7-645EF71FDF14Q33925573-366FACFD-D4A9-4992-9635-8576BB21128CQ34085646-17513A7B-7793-45BC-9AC0-97788DA70C5BQ34338701-AF2EB026-14A4-4EF7-875E-4290FD2BD52DQ34346739-137591A4-29DF-4BE3-93CE-05FA52230A07Q34374129-1A14E82B-F8E6-4664-B57E-C78CA01DDA3BQ34598510-33B1CCD5-EB1A-40A8-BD81-FA1C7C5673CEQ34718307-C14DDB9B-D2A8-411D-A56A-0AD9AF987B6CQ34776721-DC6C7A2A-02CF-40AA-AD45-39E88E13847AQ34800168-12362162-3E8E-47E8-9BFB-523EE0CE026DQ35002968-105CC570-A32A-4567-A985-A89D02ECD0CFQ35070396-2C2AB4C3-03AB-462C-8C01-518A576F00F7Q35080996-B01AA573-9D77-4AE3-8F57-2D478B9BA6ACQ35172669-258100F4-6B64-46E3-A28B-A1B9901E3C25Q35579822-962F1BB7-A98A-40AC-96B8-B89DA7F849A8Q35610595-6ED49D9D-EF9F-4150-8ACC-550F50BF88C9Q35615152-3AF59A3D-FD12-45DE-B405-B62F243D39EFQ35620798-AD85E27D-2EF3-4F86-8AEA-3DB7F4CC31BDQ35688140-4CABC308-0040-4331-93BA-56CDADDD6C6AQ35773229-94BB85D5-81A1-4889-B55D-66AE192B40CEQ35922886-E0905107-556A-453A-9A4D-01432CC72F8AQ36003192-1990AEFD-8166-40C9-9B94-68B2A783A725Q36158687-F11BBC5C-3FE3-42F7-9D41-8D18D9973927Q36182948-F6B8CD7A-4AE1-494A-A6DB-78111FC1ED38Q36315787-A7D9866F-E668-47A3-B138-C4A47FD88C26Q36481069-A4589682-2F9A-4DE1-BF41-F67B8B7E4043Q36538348-ECEC6776-8D17-4F3A-8A99-189CA801CBEEQ36764413-9115E6B3-B75A-4BF0-8E88-1E3F32FAAE9E
P2860
Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Increased glycogen synthase ki ...... nd obesity-prone C57BL/6J mice
@ast
Increased glycogen synthase ki ...... nd obesity-prone C57BL/6J mice
@en
Increased glycogen synthase ki ...... nd obesity-prone C57BL/6J mice
@nl
type
label
Increased glycogen synthase ki ...... nd obesity-prone C57BL/6J mice
@ast
Increased glycogen synthase ki ...... nd obesity-prone C57BL/6J mice
@en
Increased glycogen synthase ki ...... nd obesity-prone C57BL/6J mice
@nl
prefLabel
Increased glycogen synthase ki ...... nd obesity-prone C57BL/6J mice
@ast
Increased glycogen synthase ki ...... nd obesity-prone C57BL/6J mice
@en
Increased glycogen synthase ki ...... nd obesity-prone C57BL/6J mice
@nl
P2093
P3181
P1433
P1476
Increased glycogen synthase ki ...... nd obesity-prone C57BL/6J mice
@en
P2093
H Eldar-Finkelman
M M Shinohara
R C LeBoeuf
S A Schreyer
P304
P3181
P356
10.2337/DIABETES.48.8.1662
P407
P577
1999-08-01T00:00:00Z